The financing will support development of a commercial instrument system based on the company’s proprietary and disruptive MAGNA™ technology. MAGNA™ is set to unlock the field of dynamic genomics. Funds raised from a global investor syndicate led by Lansdowne Partners and Bpifrance and supported by funds bringing additional experience in the life science sector. Paris, […]